mdlinx mdlinx

Psychiatry - Neuro/Psych Pharmacol News & Articles

MDLinx Psychiatry is your one-stop shop for the peer-reviewed journal articles published in your field. We sort, rank and summarize the literature within 24 hours – hot off the presses! – so you can stay current without drowning in those piles of Current Psychiatry, Bipolar Disorders, and American Journal of Psychiatry. Also find bonus content like clinical pearls from The Smartest Psychiatrist Physician Review and daily quiz competition. Not sure where to start? Skim some of the recent “must read” articles highlighted by our own physician editor D. Scott Cunningham, MD, PhD.

Your Unread Messages in Psychiatry

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Articles

Latest (2) Full Text Articles (87) Focus on Personality Disorders
Ranked, sorted, and summarized by MDLinx editors from the latest literature
Topics:

321 Inappropriate long-term use of antipsychotic drugs is common among people with dementia living in specialized care units Full Text BMC Pharmacology & Toxicology, February 15, 2013    Review Article

322 The Declining Efficacy of Naltrexone Pharmacotherapy for Alcohol Use Disorders Over Time: A Multivariate Meta-Analysis Alcoholism: Clinical and Experimental Research, February 14, 2013

323 Clinical outcomes of long-acting risperidone in recent versus long-term diagnosed Belgian schizophrenic patients Early Intervention in Psychiatry, February 14, 2013    Clinical Article

324 A UK panel consensus on the initiation of aripiprazole for the treatment of bipolar mania International Journal of Psychiatry in Clinical Practice, February 14, 2013    Clinical Article

325 Hippocampal Granule Neuron Number and Dentate Gyrus Volume in Antidepressant-Treated and Untreated Major Depression Neuropsychopharmacology, February 14, 2013    Review Article

326 The Selective Dopamine beta-Hydroxylase Inhibitor Nepicastat Attenuates Multiple Aspects of Cocaine-Seeking Behavior Neuropsychopharmacology, February 14, 2013    Review Article

327 Clonazepam for the Treatment of Panic Disorder Current Drug Targets, February 13, 2013    Review Article    Clinical Article

328 A randomized, double-blind, placebo-controlled 6-wk trial of the efficacy and tolerability of 5 mg vortioxetine in adults with major depressive disorder International Journal of Neuropsychopharmacology, February 13, 2013    Clinical Article

329 Comparison of methohexital and etomidate as anesthetic agents for electroconvulsive therapy in affective and psychotic disorders Journal of Psychiatric Research, February 13, 2013    Clinical Article

330 Modification of cocaine self-administration by buspirone (buspar): potential involvement of D3 and D4 dopamine receptors International Journal of Neuropsychopharmacology, February 13, 2013    Review Article

331 Striatal glutamate and the conversion to psychosis: a prospective 1 H-MRS imaging study International Journal of Neuropsychopharmacology, February 13, 2013    Review Article

332 A pilot study of full-dose ondansetron to treat heavy-drinking men withdrawing from alcohol in Brazil Addictive Behaviours, February 13, 2013    Clinical Article

333 Bone Loss Associated with Hyperprolactinemia in Patients with Schizophrenia Clinical Schizophrenia & Related Psychoses, February 12, 2013    Clinical Article

334 Methadone Dosing and Prescribed Medication Use in a Prospective Cohort of Opioid-Dependent Pregnant Women Addiction, February 12, 2013    Clinical Article

335 Improving Treatment Adherence in Your Patients with Schizophrenia: The STAY Initiative Clinical Drug Investigation, February 12, 2013    Review Article

336 Employment-Based Reinforcement of Adherence to Oral Naltrexone Treatment in Unemployed Injection Drug Users. Experimental and Clinical Psychopharmacology, February 12, 2013    Review Article

337 Prevalence of Concomitant Use of Alcohol and Sedative-Hypnotic Drugs in Middle and Older Aged Persons: A Systematic Review Annals of Pharmacotherapy, February 12, 2013    Review Article

338 Torsades de Pointes After Administration of Low-Dose Aripiprazole Annals of Pharmacotherapy, February 12, 2013    Clinical Article

339 Recurrent major depressive disorder: Imbalance of neurokinin (NK)-1 and NK-2 receptor expression in monocytes Pharmacological Research , February 12, 2013    Review Article

340 Kava for the Treatment of Generalized Anxiety Disorder RCT: Analysis of Adverse Reactions, Liver Function, Addiction, and Sexual Effects Phytotherapy Research, February 11, 2013    Review Article

50 available pages First Previous 17 18 19 20 21 22 23 24 25 26 Next Last

Clinical Pearls in Psychiatry

Highlights in Psychiatry

Risk factors for postpartum depression

As published in the American Journal of Obstetrics and Gynecology, risk factors for postpartum depression among abused women included age 15-19 (aOR=2.29) and > 35 years of age (aOR=2.33). In non-abused women, risk factors for postpartum depression include unemployment (aOR=1.41), foreign birth (aOR=2.04), and low income (aOR=1.68). Postpartum depression was also associated with women abused prior to pregnancy (aOR=3.28), abuse beginning postpartum (aOR=4.76), and abuse resuming postpartum (aOR=3.81).

Read the article summary

A link between cardiovascular fitness and depression

As published in the British Journal of Psychiatry, low cardiovascular fitness at 18 years of age (n = 1,117,292; follow-up, 3-40 y) is associated with an increased risk of severe depression (HR = 1.96).

Read the article summary

Optimal dose of amisulpride for acute exacerbation of schizophrenia

As published in Clinical Drug Investigation, an initial amisulpride dose of 800 mg (n=38) is more effective that 400 mg with dose titration (n=30) in patients with an acute exacerbation of schizophrenia. A greater number of patients in the 800 mg group than the 400 mg with dose titration group had a 30% reduction in the Positive and Negative Symptom Scale after 4 (68.4% vs. 40.0%) and 6 weeks (71.1% vs. 43.3%).

Read the article summary

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Most Popular Psychiatry Articles

Last month's top read Top Articles of 2012

1 Post-traumatic stress disorder: new directions in pharmacotherapy Advances in Psychiatric Treatment, May 3, 2013    Review Article

2 The Combined Treatment of Venlafaxine and Quetiapine for Treatment-Resistant Depression: A Clinical Study The Journal of Neuropsychiatry & Clinical Neurosciences, May 21, 2013

3 Curcumin as an Add-On to Antidepressive Treatment: A Randomized, Double-Blind, Placebo-Controlled, Pilot Clinical Study Clinical Neuropharmacology, May 16, 2013

4 Effects of repeated dosing with mirtazapine, trazodone, or placebo on driving performance and cognitive function in healthy volunteers Human Psychopharmacology: Clinical and Experimental, May 13, 2013

5 Efficacy and safety of fluoxetine monotherapy in bipolar depression: a systematic review Expert Opinion on Pharmacotherapy, May 22, 2013

6 Lithiums role in neural plasticity and its implications for mood disorders Acta Psychiatrica Scandinavica, May 1, 2013    Review Article

7 Benzodiazepines for psychosis-induced aggression or agitation Cochrane Reviews, May 9, 2013

8 Benefits of combined cholinesterase inhibitor and memantine treatment in moderate-severe Alzheimers disease Alzheimer's & Dementia, May 14, 2013    Review Article

9 Risperidone, quetiapine, and olanzapine adjunctive treatments in major depression with psychotic features: a comparative study Neuropsychiatric Disease and Treatment, April 18, 2013    Free full text

10 Use of lisdexamfetamine dimesylate in treatment of executive functioning deficits and chronic fatigue syndrome: A double blind, placebo-controlled study Psychiatry Research, May 2, 2013

11 Aripiprazole, Ziprasidone and Quetiapine in the treatment of first-episode nonaffective psychosis: A 12-week randomized, flexible-dose, open-label trial Schizophrenia Research, May 6, 2013

12 The sertraline versus electrical current therapy for treating depression clinical study (SELECT-TDCS): results of the crossover and follow-up phases Depression and Anxiety, April 29, 2013

13 Is it possible to evaluate true prophylactic efficacy of antidepressants in severely ill patients with recurrent depression? Lessons from a placebo-controlled trial Journal of Affective Disorders, May 17, 2013

14 Treatment or "high": benzodiazepine use in patients on injectable heroin or oral opioids Addictive Behaviours, May 24, 2013

15 Mood disorders and complementary and alternative medicine: a literature review Neuropsychiatric Disease and Treatment, May 29, 2013    Free full text    Review Article

16 Nidotherapy for people with schizophrenia Cochrane Reviews, April 11, 2013    Evidence Based Medicine

17 Augmentation with Atypical Antipsychotics for Depression: A Review of Evidence-Based Support from the Medical Literature Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, March 13, 2013    Evidence Based Medicine

18 Fifty-two-week continuous abstinence rates of smokers being treated with varenicline versus nicotine replacement therapy Addiction, May 15, 2013

19 Retrospective analysis of factors associated with quetiapine dosage in the acute and subsequent six-month maintenance treatment of bipolar disorders Neuropsychiatric Disease and Treatment, May 7, 2013    Free full text

20 Amphetamine, past and present - a pharmacological and clinical perspective Journal of Psychopharmacology, May 16, 2013    Review Article

Indexed Journals in Psychiatry : Current Psychiatry, Bipolar Disorders, American Journal of Psychiatry, Addictionmore

Other Topics in Psychiatry

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close